Actively Recruiting
Tender Loving Care for Recurrent Pregnancy Loss
Led by Walter Reed National Military Medical Center · Updated on 2026-04-22
60
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this investigational study is to evaluate participation in a weekly, interactive, tender loving care messaging platform impact on pregnancy outcomes in patients with recurrent pregnancy loss. The main questions it aims to answer are: (1) does participation in weekly, interactive tender loving care messages increase live birth rates in patients with recurrent pregnancy loss? (2) Does participation in weekly, interactive tender loving care messages increase patients' quality of life? Does participation in weekly, interactive tender loving care messages decrease patients' depressive symptoms? Participants will be asked to interact with weekly messages providing prenatal counseling and support. Additionally, patients will be asked to complete the fertility quality of life survey several times over the course of the pregnancy.
CONDITIONS
Official Title
Tender Loving Care for Recurrent Pregnancy Loss
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant individuals receiving their prenatal care at WRNMMC
- Able to speak and understand English
- Less than or equal to 10+0 weeks gestation by last menstrual period or dating ultrasound at enrollment
- At least two prior pregnancy losses confirmed by laboratory or ultrasound with subsequent resolution
You will not qualify if you...
- Age less than 18 years or older than 44 years at enrollment
- Unable to speak or understand English
- Current smoker or tobacco use within 30 days
- History of uterine anomaly, coagulopathy, balanced translocation, endometrial polyps, submucosal fibroids, acute or chronic endometritis, hydrosalpinx, Asherman syndrome, poorly controlled endocrinopathies, or HIV infection
- History of gonadotoxic therapy or cancer of the female reproductive tract
- Suspicion or confirmation of an ectopic pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Walter Reed National Military Medical Center
Bethesda, Maryland, United States, 20814
Actively Recruiting
Research Team
D
David Boedeker, DO
CONTACT
K
Kiley Hunkler, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here